Combined treatment with omalizumab and etanercept in a patient with chronic spontaneous urticaria and rheumatoid arthritis

Abstract

We present a case report of a 64-year old female patient with rheumatoid arthritis and chronic spontaneous urticaria. She was treated with a combination of etanercept and omalizumab with good results and no adverse effects. In selected patients with severe inflammatory disease activity it is worth considering combined biologic therapy. However, treatment should be closely monitored as short-term and long-term side effects are not properly elucidated.

Original languageEnglish
JournalThe Journal of dermatological treatment
Volume30
Issue number4
Pages (from-to)387-388
Number of pages2
ISSN0954-6634
DOIs
Publication statusPublished - Jun 2019

Keywords

  • Adult
  • Anti-Allergic Agents/therapeutic use
  • Antirheumatic Agents/therapeutic use
  • Arthritis, Rheumatoid/drug therapy
  • Chronic Disease
  • Drug Therapy, Combination
  • Etanercept/therapeutic use
  • Female
  • Humans
  • Omalizumab/therapeutic use
  • Urticaria/drug therapy

Fingerprint

Dive into the research topics of 'Combined treatment with omalizumab and etanercept in a patient with chronic spontaneous urticaria and rheumatoid arthritis'. Together they form a unique fingerprint.

Cite this